These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16293086)

  • 1. Bioactive technologies for hemocompatibility.
    Tanzi MC
    Expert Rev Med Devices; 2005 Jul; 2(4):473-92. PubMed ID: 16293086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation.
    Wendel HP; Ziemer G
    Eur J Cardiothorac Surg; 1999 Sep; 16(3):342-50. PubMed ID: 10554855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of anticoagulant biomaterial and its development].
    Chen B; Huo D; Rao J; Hou C; Li M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2005 Apr; 22(2):428-32. PubMed ID: 15884572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Basic science review: nitric oxide--releasing prosthetic materials.
    Varu VN; Tsihlis ND; Kibbe MR
    Vasc Endovascular Surg; 2009; 43(2):121-31. PubMed ID: 18799500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review of heparin immobilization technique].
    Ma K; Gao W; Cai S; Wang X
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Apr; 24(2):466-9. PubMed ID: 17591284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface coatings for ventricular assist devices.
    Sin DC; Kei HL; Miao X
    Expert Rev Med Devices; 2009 Jan; 6(1):51-60. PubMed ID: 19105780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Currently available biomaterials for use in cardiopulmonary bypass.
    Belway D; Rubens FD
    Expert Rev Med Devices; 2006 May; 3(3):345-55. PubMed ID: 16681456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S; Farsak B; McCusker K; Vijay V; Sari T; Onur MA; Gurpinar A; Zorlutuna Y
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phospholipid-modified polystyrene-polyisobutylene-polystyrene (SIBS) triblock polymer for enhanced hemocompatibility and potential use in artificial heart valves.
    Duraiswamy N; Choksi TD; Pinchuk L; Schoephoerster RT
    J Biomater Appl; 2009 Jan; 23(4):367-79. PubMed ID: 18697881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronary stents: a materials perspective.
    Mani G; Feldman MD; Patel D; Agrawal CM
    Biomaterials; 2007 Mar; 28(9):1689-710. PubMed ID: 17188349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an alternative to systemic anticoagulation, as related to interventional biomedical devices?
    Conn G; Kidane AG; Punshon G; Kannan RY; Hamilton G; Seifalian AM
    Expert Rev Med Devices; 2006 Mar; 3(2):245-61. PubMed ID: 16515390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of whole blood in thrombin generation in contact with various titanium surfaces.
    Thor A; Rasmusson L; Wennerberg A; Thomsen P; Hirsch JM; Nilsson B; Hong J
    Biomaterials; 2007 Feb; 28(6):966-74. PubMed ID: 17095084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study on a novel vascular stent material (titanium oxide, Ti-O) coated with albumin and heparin: is it hemocompatible with fibrinogen].
    Song J; Wu X; Huang N; Xu B; Jing F; Chen J; Leng Y; Yang P; Wang J; Sun H; Zhao A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Oct; 24(5):1097-101. PubMed ID: 18027705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An in vitro method for assessing biomaterial-associated platelet activation.
    LaFayette NG; Skrzypchak AM; Merz S; Bartlett RH; Annich GM
    ASAIO J; 2007; 53(2):159-62. PubMed ID: 17413554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endovascular device design in the future: transformation from trial and error to computational design.
    Zarins CK; Taylor CA
    J Endovasc Ther; 2009 Feb; 16 Suppl 1():I12-21. PubMed ID: 19317584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of endothelial cell phenotype by biomimetic matrix coated on biomaterials for cardiovascular tissue engineering.
    Prasad CK; Krishnan LK
    Acta Biomater; 2008 Jan; 4(1):182-91. PubMed ID: 17643359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro hemocompatibility of albumin-heparin multilayer coatings on polyethersulfone prepared by the layer-by-layer technique.
    Sperling C; Houska M; Brynda E; Streller U; Werner C
    J Biomed Mater Res A; 2006 Mar; 76(4):681-9. PubMed ID: 16302224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemocompatibility testing according to ISO 10993-4: discrimination between pyrogen- and device-induced hemostatic activation.
    Stang K; Krajewski S; Neumann B; Kurz J; Post M; Stoppelkamp S; Fennrich S; Avci-Adali M; Armbruster D; Schlensak C; Burgener IA; Wendel HP; Walker T
    Mater Sci Eng C Mater Biol Appl; 2014 Sep; 42():422-8. PubMed ID: 25063137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human osteoblast-like cell adhesion on titanium substrates covalently functionalized with synthetic peptides.
    Bagno A; Piovan A; Dettin M; Chiarion A; Brun P; Gambaretto R; Fontana G; Di Bello C; Palù G; Castagliuolo I
    Bone; 2007 Mar; 40(3):693-9. PubMed ID: 17142122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive porous titanium: an alternative to surgical implants.
    de Medeiros WS; de Oliveira MV; Pereira LC; de Andrade MC
    Artif Organs; 2008 Apr; 32(4):277-82. PubMed ID: 18370941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.